A Fragile Phosphate/Pyrophosphate Balance: From Essential Mineralization to Rare Calcifying Diseases
- PMID: 40768170
- DOI: 10.1007/s11914-025-00928-z
A Fragile Phosphate/Pyrophosphate Balance: From Essential Mineralization to Rare Calcifying Diseases
Abstract
Purpose of review: Calcification, the deposition of phosphate-calcium crystals, is essential for the development and function of mineralized tissues. When dysregulated, it can cause harmful effects. This review focuses on the critical role of the balance between phosphate (Pi) and pyrophosphate (PPi) in maintaining healthy mineralization and explains how disruptions in this balance contribute to rare calcifying disorders.
Recent findings: Studies have identified key regulators of PPi production and Pi generation. Recent research on rare calcifying diseases and animal models has revealed how Pi/PPi imbalances lead to ectopic calcification in soft tissues, driving disease progression. The balance of Pi/PPi is vital for bone health and preventing pathological calcification. Disruptions in this equilibrium contribute to rare diseases. Understanding these mechanisms, supported by preclinical models, opens potential therapeutic avenues to restore balance and mitigate the impact of these diseases.
Keywords: Phosphate; Pyrophosphate, mineralization, ectopic calcification; Rare diseases; Therapeutic strategy.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Competing Interests: The authors declare no competing interests.
Similar articles
-
Structural and molecular imaging-based characterization of soft tissue and vascular calcification in hyperphosphatemic familial tumoral calcinosis.J Bone Miner Res. 2024 Sep 2;39(9):1327-1339. doi: 10.1093/jbmr/zjae115. J Bone Miner Res. 2024. PMID: 39046425 Free PMC article.
-
Soft tissue calcifications in chronic kidney disease-beyond the vasculature.Pflugers Arch. 2025 Aug;477(8):1037-1059. doi: 10.1007/s00424-025-03098-0. Epub 2025 Jun 5. Pflugers Arch. 2025. PMID: 40471241 Free PMC article. Review.
-
Short-Term Memory Impairment.2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
-
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).Cochrane Database Syst Rev. 2018 Aug 22;8(8):CD006023. doi: 10.1002/14651858.CD006023.pub3. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2025 Jun 27;6:CD006023. doi: 10.1002/14651858.CD006023.pub4. PMID: 30132304 Free PMC article. Updated.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
References
-
- Reznikov N, Hoac B, Buss DJ, Addison WN, Barros NMT, McKee MD. Biological stenciling of mineralization in the skeleton: local enzymatic removal of inhibitors in the extracellular matrix. Bone. 2020;138:115447. - PubMed
-
- McKee MD, Buss DJ, Reznikov N. Mineral tessellation in bone and the stenciling principle for extracellular matrix mineralization. J Struct Biol. 2022;214:107823. - PubMed
-
- Zhang J, Ma Z, Yan K, Wang Y, Yang Y, Wu X. Matrix Gla protein promotes the bone formation by up-regulating Wnt/β-Catenin signaling pathway. Front Endocrinol. 2019;10:891.
-
- Si J, Wang C, Zhang D, Wang B, Zhou Y. Osteopontin in bone metabolism and bone diseases. Med Sci Monit. 2020;26:e919159.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous